JB CHEMICALS & PHARMACEUTICALS
|
The Current P/E Ratio of JB CHEMICALS & PHARMACEUTICALS is 50.59.
| Share Price | ₹2,234.8 | Jun 23,2026 |
| Market Cap | ₹35,890.9 Cr | |
| Earnings-TTM | ₹709.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 50.59x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of JB CHEMICALS & PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹35,890.9 Cr] as on Jun 23,2026
(/) Earnings [ ₹709.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 50.59x ]
Thus, for JB CHEMICALS & PHARMACEUTICALS , the investors are currently willing to pay 50.59 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JB CHEMICALS & PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of JB CHEMICALS & PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of JB CHEMICALS & PHARMACEUTICALS
PE Ratio Performance Analysis for JB CHEMICALS & PHARMACEUTICALS
- JB CHEMICALS & PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 36.30x.
- JB CHEMICALS & PHARMACEUTICALS 's operated at median p/e ratio of 38.29x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JB CHEMICALS & PHARMACEUTICALS 's p/e ratio peaked in Mar2026 at 46.69x.
- JB CHEMICALS & PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 18.61x.
How does JB CHEMICALS & PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| JB CHEMICALS & PHARMACEUTICALS | 709.46 | 50.59 | 35,890.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 38.75 | 448,148.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 69.71 | 179,009.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 71.46 | 152,779.0 |
| CIPLA LTD | 3,869.79 | 29.92 | 115,772.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 26.21 | 108,616.0 |
| MANKIND PHARMA LTD | 1,926.41 | 54.23 | 104,478.0 |
| LUPIN LTD | 5,355.47 | 20.12 | 107,749.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.07 | 110,932.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 25.23 | 88,349.3 |
| LAURUS LABS LTD | 889.85 | 89.90 | 80,000.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JB CHEMICALS & PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 20.12x |
| Max industry PE | 89.90x |
| Median industry PE | 38.75x |
| Average industry PE | 45.29x |
You may also like the below Video Courses